loader
Please Wait
Applying Filters...

Renejix CDMO Partner for Small Molecule Oral Dosage Forms Renejix CDMO Partner for Small Molecule Oral Dosage Forms

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about Etofibrate, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    Etofibrate

    APIs // Active Pharmaceutical Ingredients

    PharmaCompass

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    2D Structure
    1. Also known as: 31637-97-5, Etofibrate [inn], 2-[2-(4-chlorophenoxy)-2-methylpropanoyl]oxyethyl pyridine-3-carboxylate, Ethofibrate, 23tf67g79m, Etofibrate (inn)
    Molecular Formula
    C18H18ClNO5
    Molecular Weight
    363.8  g/mol
    InChI Key
    XXRVYAFBUDSLJX-UHFFFAOYSA-N
    FDA UNII
    23TF67G79M
    Etofibrate is an orally-available combination of clofibrate and niacin linked together by an ester bond. In the body clofibrate and niacin separate, acting as a controlled-release formulation.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    2-[2-(4-chlorophenoxy)-2-methylpropanoyl]oxyethyl pyridine-3-carboxylate
    2.1.2 InChI
    InChI=1S/C18H18ClNO5/c1-18(2,25-15-7-5-14(19)6-8-15)17(22)24-11-10-23-16(21)13-4-3-9-20-12-13/h3-9,12H,10-11H2,1-2H3
    2.1.3 InChI Key
    XXRVYAFBUDSLJX-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    CC(C)(C(=O)OCCOC(=O)C1=CN=CC=C1)OC2=CC=C(C=C2)Cl
    2.2 Other Identifiers
    2.2.1 UNII
    23TF67G79M
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. Etofibrate Hydrochloride

    2. Lipo-merz

    3. Tricerol

    2.3.2 Depositor-Supplied Synonyms

    1. 31637-97-5

    2. Etofibrate [inn]

    3. 2-[2-(4-chlorophenoxy)-2-methylpropanoyl]oxyethyl Pyridine-3-carboxylate

    4. Ethofibrate

    5. 23tf67g79m

    6. Etofibrate (inn)

    7. Lipo-merz

    8. 2-hydroxyethyl Nicotinate 2-(p-chlorophenoxy)-2-methylpropionate (ester)

    9. Etofibrato

    10. Etofibratum

    11. 2-(2-(4-chlorophenoxy)-2-methylpropanoyloxy)ethyl Nicotinate

    12. Etofibratum [inn-latin]

    13. Etofibrato [inn-spanish]

    14. Einecs 250-743-1

    15. Unii-23tf67g79m

    16. Etofibrate [mi]

    17. Etofibrate [mart.]

    18. Schembl3122

    19. 3-pyridinecarboxylic Acid, 2-[2-(4-chlorophenoxy)-2-methyl-1-oxopropoxy]ethyl Ester

    20. Etofibrate [who-dd]

    21. Mls006010106

    22. Etofibrate, Analytical Standard

    23. Chembl358150

    24. Dtxsid80185521

    25. Chebi:135535

    26. Hms3652n04

    27. 2-((2-(4-chlorophenoxy)-2-methylpropanoyl)oxy)ethyl Nicotinate

    28. Bcp07572

    29. Hy-a0127

    30. Zinc2019929

    31. Mfcd00865727

    32. 2-(p-chlorophenoxy)-2-methylpropionic Acid 2-(nicotinoyloxy)ethyl Ester

    33. Akos025311314

    34. Ccg-268206

    35. Db08983

    36. 121ge005

    37. Ac-23121

    38. As-16847

    39. Smr002529563

    40. Cs-0017444

    41. E1359

    42. Ft-0660287

    43. S4264

    44. Sw219681-1

    45. D07187

    46. T72280

    47. 637e975

    48. Q-201101

    49. Q4116990

    2.4 Create Date
    2005-08-08
    3 Chemical and Physical Properties
    Molecular Weight 363.8 g/mol
    Molecular Formula C18H18ClNO5
    XLogP33.5
    Hydrogen Bond Donor Count0
    Hydrogen Bond Acceptor Count6
    Rotatable Bond Count9
    Exact Mass363.0873504 g/mol
    Monoisotopic Mass363.0873504 g/mol
    Topological Polar Surface Area74.7 Ų
    Heavy Atom Count25
    Formal Charge0
    Complexity449
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Pharmacology and Biochemistry
    4.1 MeSH Pharmacological Classification

    Hypolipidemic Agents

    Substances that lower the levels of certain LIPIDS in the BLOOD. They are used to treat HYPERLIPIDEMIAS. (See all compounds classified as Hypolipidemic Agents.)

    Anticholesteremic Agents

    Substances used to lower plasma cholesterol levels. (See all compounds classified as Anticholesteremic Agents.)

    4.2 ATC Code

    C - Cardiovascular system

    C10 - Lipid modifying agents

    C10A - Lipid modifying agents, plain

    C10AB - Fibrates

    C10AB09 - Etofibrate

    Post Enquiry
    POST ENQUIRY